Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

"Anti-obesity medications are emerging at an astonishing pace," Dr. Christopher McGowan, a gastroenterologist and obesity medicine specialist ... than current medications like Ozempic, Wegovy, and ...

The drug - in the form of its Mounjaro KwikPen device - was approved by the UK's ... Back in June, the Society for Acute Medicine warned that doctors were treating "increasing numbers" of patients ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

In the case of Ms Susan McGowan’s death, it is believed to be the first time the drug tirzepatide, known under the brand name ...

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

An influencer, known as Heather, has organised a party celebrating weight loss jab tirzepatide, close to where NHS worker ...

It is thought to be the first time the medicine has been listed as a contributing factor on a death certificate. Like all drugs, Mounjaro is not without side-effects. Yet speaking to MailOnline ...

Mounjaro was approved based on extensive assessment of the benefits and risks of the medicine, and we provide information ...

Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...